Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for advanced cancer: experimental drug BHV-1530 enters first human tests

NCT ID NCT06874335

Recruiting now Disease control Sponsor: Biohaven Therapeutics Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This early-stage trial tests a new drug called BHV-1530 in about 95 adults whose solid tumors have spread or cannot be removed. The main goals are to find a safe dose and check for side effects. Researchers will also watch for signs that the drug shrinks tumors or slows the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck squamous cell carcinoma neoplasm non-small cell lung carcinoma urothelial carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID TUMOR

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Site-101

    RECRUITING

    Irving, Texas, 75039, United States

  • Site-102

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Site-103

    RECRUITING

    Austin, Texas, 78758, United States

  • Site-104

    RECRUITING

    Houston, Texas, 77030, United States

  • Site-105

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Site-106

    RECRUITING

    West Valley City, Utah, 84119, United States

  • Site-107

    RECRUITING

    Denver, Colorado, 80218, United States

  • Site-108

    WITHDRAWN

    Lake Mary, Florida, 32746, United States

  • Site-110

    RECRUITING

    Detroit, Michigan, 48201, United States

  • Site-111

    RECRUITING

    Newport Beach, California, 92663, United States

  • Site-112

    RECRUITING

    Myrtle Beach, South Carolina, 29572, United States

  • Site-115

    RECRUITING

    Durham, North Carolina, 27710, United States

  • Site-116

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Site-118

    RECRUITING

    Orlando, Florida, 32804, United States

  • Site-120

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • Site-121

    RECRUITING

    Miami, Florida, 33136, United States

  • Site-122

    RECRUITING

    Cleveland, Ohio, 44195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.